Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 7/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 6/20 | 0.54 |
| ▸ | USP2 | O75604 | 5/20 | 0.54 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | IRAK4 | Q9NWZ3 | 12/20 | 0.51 |
| ▸ | TSHR | P16473 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4184932 | 0.88 | CYP2D6 (0.60) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4177368 | 0.88 | IRAK4 (0.52) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| Hydrochloric Acid SCHEMBL4167163 | 0.87 | IRAK4 (0.51) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4180240 | 0.85 | IRAK4 (0.51) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4182559 | 0.84 | IRAK4 (0.56) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4178137 | 0.84 | IRAK4 (0.46) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4170400 | 0.82 | IRAK4 (0.58) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4176532 | 0.81 | IRAK4 (0.44) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4176397 | 0.78 | CYP2D6 (0.61) | CYP1A2CYP2D6CYP3A4CYP2C19USP2 | |
| SCHEMBL4167241 | 0.76 | IRAK4 (0.54) | CYP1A2CYP3A4USP2CLK4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | claimed |
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRUENENTHAL GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069320-A1 | Substituted 4-Amino-Quinazoline Compounds with Metabotropic Glutamate Receptor Regulating Activity and Uses Thereof | GRM1, GRIN1, GRM2 | CYP1A2 4353/4885CYP2D6 4096/4885CYP3A4 4173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.